SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 367 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $14,887,600 | +98096.7% | 130,000 | +18.2% | 0.83% | -16.4% |
| Q1 2023 | $15,161 | -41.5% | 110,000 | -45.0% | 1.00% | -42.4% |
| Q4 2022 | $25,916 | -99.9% | 200,000 | 0.0% | 1.73% | +12.2% |
| Q3 2022 | $22,108,000 | +323.8% | 200,000 | +185.7% | 1.54% | +1231.9% |
| Q1 2021 | $5,217,000 | -56.3% | 70,000 | 0.0% | 0.12% | -59.2% |
| Q4 2020 | $11,934,000 | -0.0% | 70,000 | -17.6% | 0.28% | -38.1% |
| Q3 2020 | $11,937,000 | -32.3% | 85,000 | -22.7% | 0.46% | -31.8% |
| Q2 2020 | $17,637,000 | +20.2% | 110,000 | -26.7% | 0.67% | -1.3% |
| Q1 2020 | $14,673,000 | -54.5% | 150,000 | -40.0% | 0.68% | -47.0% |
| Q4 2019 | $32,260,000 | +93.2% | 250,000 | +12.8% | 1.29% | +26.7% |
| Q3 2019 | $16,698,000 | -51.2% | 221,700 | -1.5% | 1.02% | -48.3% |
| Q2 2019 | $34,189,000 | -4.4% | 225,000 | -25.0% | 1.96% | -18.7% |
| Q1 2019 | $35,757,000 | +264.1% | 300,000 | +233.3% | 2.42% | +203.3% |
| Q4 2018 | $9,822,000 | – | 90,000 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |